1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Growing Burden of Lifestyle Diseases in Emerging Countries 

Growing Burden of Lifestyle Diseases in Emerging Countries 

  • February 2016
  • -
  • Frost & Sullivan
  • -
  • 59 pages

Growing Burden of Lifestyle Diseases in Emerging Countries : The Healthcare and Life Sciences Growth Trajectory Beyond BRICS

While low and middle income group countries are typically characterized by a high burden of communicable diseases, the trend appears to be changing. By 2030, NCDs are expected to account for nearly 55% of the disease burden of these country groups. A growing middle aged population increases the risk of NCDs in the low and middle income country groups, especially Asia, Africa, and parts of Latin America. Growth in burden of NCDs—diabetes and cardiovascular diseases—not only calls for greater healthcare infrastructure and a larger healthcare workforce but also adequate preventive care. The initiatives of the government to develop eHealth in some countries open up avenues for investment in areas, such as tele-medicine, healthcare platforms and application software, and electronic health records.

Executive Summary

The global burden of disease is gradually shifting towards non-communicable diseases (NCDs). By 2030, non-communicable diseases are anticipated to be the cause of nearly % of global deaths, up from % in 2000.
The risk factors associated with communicable diseases have grown significantly over the last decade, with the growth in living standards in developing nations all over the world.
The prevalence of NCD risk factors like smoking, alcohol consumption and obesity are anticipated to grow at a faster rate in developing countries compared to developed countries during 2015–2030. However, WHO member countries are expected to be proactive in controlling the risk factors per the targets set by the Global Monitoring Framework of the WHO.
Most of the developed countries of the world are having a high proportion of old age population; the developing countries in parts of Asia and Latin America are fast growing in terms of middle aged population. As the middle aged population is prone to suffer chronic conditions like Diabetes and heart diseases, the Asian and Latin American countries are at a risk of high growth in incidence of such diseases during 2015–2030.

Table Of Contents

Growing Burden of Lifestyle Diseases in Emerging Countries 
1 GROWING BURDEN OF LIFESTYLE DISEASES IN EMERGING COUNTRIES

Executive Summary
1 Executive Summary
2 Executive Summary

Economic Insights: Micro Boom—Definitions and Tie-ins
1 EMI—A Journey from Macro to Micro
2 What Are Economic Insights-Micro Booms?
3 Economic Insight: Micro Booms—What is the Structured Approach?

Introduction—Scope and Research Methodology
1 Issue-Based Brainstorming About Mega Trends and Emerging Markets
2 Research Methodology
3 Research Methodology

Business Insights
1 Business Insights
2 Global Disease Burden Landscape
3 Disease Bucket
4 Shifting Disease Burden
5 What Caused the Epidemiological Shift in Developing Countries?
6 Non Communicable Diseases—Diseases of Affluence
7 Income Induced Risk Factor Growth in Developing countries
8 Global Market for NCDs—Risks and Disease

Growth Insights
1 Growth Insights
2 NCDs—Behavioral and Metabolic Risks for Top Countries
3 Global Monitoring Framework by WHO
4 Behavioral Risk Factors—Smoking Prevalence
5 Behavioral Risk Factors—Alcohol Consumption
6 Behavioral Risk Factors—Inadequate Physical Activity
7 Disease Vulnerability by Demographic Median Age Group
8 Disease Vulnerability by Demographic Median Age Group

Profit Insights
1 Profit Insights
2 Healthcare Expenditure Growth in High NCD-Burdened Countries
3 Current and Mid-term Focus Areas in NCD-Burdened Countries
4 Why Invest in Indonesia?
5 Indonesian Healthcare at the Early Stage of Growth
6 Indonesia—Hospital Distribution by Province
7 Indonesia—Target Cities for Healthcare Infrastructure Expansion
8 Indonesia—Top Hospitals by City
9 What is Driving the Need for Preventive Care in Mexico?
10 Mexican Healthcare—Challenges and Unmet Needs
11 Mexican Healthcare—Development and Opportunities
12 Evolution of EHR in Mexican Public Institutions and Hospitals
13 Mexico—Distribution of Hospitals
14 Conclusion and Key Takeaway
15 Legal Disclaimer

Appendix
1 Important Definitions
2 Important Definitions
3 List of Abbreviations

The Frost and Sullivan Story
1 The Frost and Sullivan Story
2 Value Proposition—Future of Your Company and Career
3 Global Perspective
4 Industry Convergence
5 360º Research Perspective
6 Implementation Excellence
7 Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Personal mobility devices such as wheelchairs, mobility scooters, and stair lifts have witnessed significant growth in revenue and volume in the past few years. A personal mobility device is either a manual ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.